Teladoc Health, Inc. (NYSE:TDOC – Free Report) – Stock analysts at KeyCorp cut their Q3 2023 earnings estimates for shares of Teladoc Health in a research note issued to investors on Wednesday, July 26th. KeyCorp analyst S. Schoenhaus now expects that the health services provider will post earnings per share of ($0.34) for the quarter, down from their prior estimate of ($0.32). The consensus estimate for Teladoc Health’s current full-year earnings is ($1.43) per share. KeyCorp also issued estimates for Teladoc Health’s Q4 2023 earnings at ($0.20) EPS, FY2023 earnings at ($1.36) EPS, Q1 2024 earnings at ($0.28) EPS, Q2 2024 earnings at ($0.29) EPS, Q3 2024 earnings at ($0.32) EPS, Q4 2024 earnings at ($0.15) EPS, FY2024 earnings at ($1.05) EPS and FY2025 earnings at ($1.12) EPS.
Several other analysts also recently weighed in on TDOC. Citigroup dropped their target price on shares of Teladoc Health from $31.00 to $29.00 in a research report on Wednesday, July 26th. 58.com reaffirmed a “maintains” rating on shares of Teladoc Health in a report on Thursday, April 27th. VNET Group reaffirmed a “maintains” rating on shares of Teladoc Health in a report on Thursday, April 27th. 888 reissued a “maintains” rating on shares of Teladoc Health in a report on Friday, April 28th. Finally, Barclays increased their price target on shares of Teladoc Health from $28.00 to $29.00 in a report on Thursday, April 27th. One research analyst has rated the stock with a sell rating, thirteen have given a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, Teladoc Health currently has an average rating of “Hold” and a consensus price target of $31.22.
Teladoc Health Stock Up 1.1 %
Teladoc Health (NYSE:TDOC – Get Free Report) last issued its quarterly earnings data on Tuesday, July 25th. The health services provider reported ($0.40) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.04. Teladoc Health had a negative net margin of 158.76% and a negative return on equity of 6.67%. The firm had revenue of $652.41 million for the quarter, compared to the consensus estimate of $649.20 million. During the same quarter in the previous year, the firm earned ($0.44) EPS. The company’s quarterly revenue was up 10.1% compared to the same quarter last year.
Insiders Place Their Bets
In other news, insider Vidya Raman-Tangella sold 15,372 shares of Teladoc Health stock in a transaction on Tuesday, May 2nd. The shares were sold at an average price of $26.76, for a total value of $411,354.72. Following the transaction, the insider now directly owns 25,620 shares of the company’s stock, valued at approximately $685,591.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Teladoc Health news, insider Vidya Raman-Tangella sold 15,372 shares of the business’s stock in a transaction on Tuesday, May 2nd. The shares were sold at an average price of $26.76, for a total value of $411,354.72. Following the transaction, the insider now directly owns 25,620 shares of the company’s stock, valued at approximately $685,591.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Claus Torp Jensen sold 6,547 shares of the business’s stock in a transaction on Wednesday, July 26th. The shares were sold at an average price of $29.00, for a total transaction of $189,863.00. Following the completion of the transaction, the insider now directly owns 13,096 shares in the company, valued at $379,784. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 36,011 shares of company stock valued at $999,473. 1.63% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Teladoc Health
Several institutional investors have recently made changes to their positions in the stock. Lindbrook Capital LLC boosted its position in shares of Teladoc Health by 11.6% during the 4th quarter. Lindbrook Capital LLC now owns 3,655 shares of the health services provider’s stock worth $86,000 after purchasing an additional 381 shares in the last quarter. National Bank of Canada FI boosted its position in shares of Teladoc Health by 4.8% in the 2nd quarter. National Bank of Canada FI now owns 8,503 shares of the health services provider’s stock worth $215,000 after buying an additional 387 shares in the last quarter. Forum Financial Management LP boosted its position in shares of Teladoc Health by 14.4% in the 1st quarter. Forum Financial Management LP now owns 3,094 shares of the health services provider’s stock worth $223,000 after buying an additional 390 shares in the last quarter. Amalgamated Bank boosted its position in shares of Teladoc Health by 1.3% in the 4th quarter. Amalgamated Bank now owns 30,399 shares of the health services provider’s stock worth $719,000 after buying an additional 392 shares in the last quarter. Finally, Treasurer of the State of North Carolina boosted its position in shares of Teladoc Health by 0.7% in the 1st quarter. Treasurer of the State of North Carolina now owns 70,207 shares of the health services provider’s stock worth $1,818,000 after buying an additional 500 shares in the last quarter. 81.81% of the stock is currently owned by hedge funds and other institutional investors.
Teladoc Health Company Profile
Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company operates through two segments, Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Articles
- Five stocks we like better than Teladoc Health
- What is Short Interest? How to Use It
- MarketBeat Week in Review – 7/24 – 7/28
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- Can SAIA Continue its Stratospheric Rally?
- There Are Different Types of Stock To Invest In
- Why Markets Are Loving Exxon Mobil, Despite The Earnings Dip
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.
